Articles related to CANCER RISK

N-nitroso-duloxetine poses increased cancer risk at higher concentrations and extended exposure periods, prompting FDA-mandated strict limits on nitrosamine levels in medications.

One in eight women will develop breast cancer in her lifetime, with risk-reducing medications showing up to 65% reduction in annual incidence, yet these interventions remain vastly underutilized in clinical practice.

New-onset diabetes in patients over 50 may serve as an early warning sign of pancreatic cancer, with research showing a 1-3 year presence of diabetes before cancer diagnosis in many cases.

Analysis of objective biomarkers in blood samples reveals that individuals with the highest levels of omega-3 or omega-6 fatty acids demonstrated 20% lower cancer mortality rates compared to those with the lowest levels.

Researchers identified the post-fast refeeding period as a distinct state with greater potential for tumor proliferation compared to the fasted or continuously fed state.

Intramuscular fat accumulation poses a significant mortality risk, potentially surpassing that of obesity and muscle wasting, according to recent research.